arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

ImmunityBio, Inc.

IBRX Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$6.92
▼ -5.1% Today
as of Jun 7, 07:17 ET
Last 30 days -0.57% Apr 28 → Jun 05
$6.79 $7.25 $7.72 $8.18 $8.64 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$7.15
High
$7.29
Low
$6.79
Volume
$14M
Avg Vol
$18M
Mkt Cap
$8.1B
P/E (TTM)
Beta
52w High
$12.43
52w Low
$1.95
Div Yield
Shares Out
$1.0B

Overview

52-week range
$1.95
$12
47% of range
Avg surprise (last 2)
-18.8%
Avg reaction (last 2)
+3.3%
50% positive
Latest IV / EM
159%
EM ±14.8% · $7 · Jun 12

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.32$-0.26$-0.20$-0.13$-0.07 Actual $-0.32Actual $-0.19Actual $-0.20Actual $-0.20Actual $-0.14Actual $-0.15Est $-0.12Actual $-0.10Actual $-0.07Actual $-0.09Est $-0.08 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-633M$-463M$-293M$-123M$46M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.09 $-0.08 -12.5% +40.0% -7.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.07 financials
Mon Jun 30, 2025Jun 2025 $-0.10 financials
Mon May 12, 2025Mar/2025 $-0.15 $-0.12 -25.0% +14.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.14 financials
Sun Jun 30, 2024Jun 2024 $-0.20 financials
Sun Mar 31, 2024Mar 2024 $-0.20 financials
Sat Sep 30, 2023Sep 2023 $-0.19 financials
Fri Jun 30, 2023Jun 2023 $-0.32 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$44M$32M$26M$17M$6M$1M
Cost of revenue$238,000$177,000$136,000$58,000$0$0
Gross profit
Operating income$-70M$-56M$-71M$-64M$-80M$-99M
Net income$-633M$-67M$-93M$-130M$-86M$-135M
EPS (diluted)$-0.62$-0.07$-0.10$-0.15$-0.14$-0.20

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$205M$88M$60M$138M$61M$143M$112M$130M
Inventory$547,000$910,000$7M$7M$8M$8M$2M$2M
Total current assets$453M$315M$329M$208M$109M$185M$163M$243M
Total assets$647M$502M$519M$402M$304M$383M$365M$444M
Long-term debt
Total liabilities$1.52B$1.00B$1.04B$972M$894M$871M$1.11B$1.14B
Total equity$-870M$-500M$-524M$-571M$-591M$-489M$-745M$-698M

Implied volatility — last 90 days

153%156%158%161%163% Jun 07 — IV 159% · EM ±14.8%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.